99 related articles for article (PubMed ID: 7641191)
1. Influence of cellular trafficking on protein synthesis inhibition of immunotoxins directed against the transferrin receptor.
Yazdi PT; Wenning LA; Murphy RM
Cancer Res; 1995 Sep; 55(17):3763-71. PubMed ID: 7641191
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of protein synthesis inhibition by transferrin-toxin conjugates.
Yazdi PT; Murphy RM
Cancer Res; 1994 Dec; 54(24):6387-94. PubMed ID: 7987833
[TBL] [Abstract][Full Text] [Related]
3. Coupled cellular trafficking and diffusional limitations in delivery of immunotoxins to multicell tumor spheroids.
Wenning LA; Murphy RM
Biotechnol Bioeng; 1999 Mar; 62(5):562-75. PubMed ID: 10099565
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of protein synthesis inhibition and recovery in CRM107 immunotoxin-treated HeLa cells.
Wenning LA; Yazdi PT; Murphy RM
Biotechnol Bioeng; 1998 Feb; 57(4):484-96. PubMed ID: 10099226
[TBL] [Abstract][Full Text] [Related]
5. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.
Scott CF; Goldmacher VS; Lambert JM; Jackson JV; McIntyre GD
J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356
[TBL] [Abstract][Full Text] [Related]
6. Properties of immunotoxins against a glycolipid antigen associated with Burkitt's lymphoma.
Wiels J; Junqua S; Dujardin P; Le Pecq JB; Tursz T
Cancer Res; 1984 Jan; 44(1):129-33. PubMed ID: 6690030
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity of gelonin conjugated to targeting molecules: effects of weak amines, monensin, adenovirus, and adenoviral capsid proteins penton, hexon, and fiber.
Goldmacher VS; Blättler WA; Lambert JM; McIntyre G; Stewart J
Mol Pharmacol; 1989 Nov; 36(5):818-22. PubMed ID: 2531272
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of transferrin receptor-targeted immunotoxins in brain tumor cell lines and pediatric brain tumors.
Martell LA; Agrawal A; Ross DA; Muraszko KM
Cancer Res; 1993 Mar; 53(6):1348-53. PubMed ID: 8443815
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of gelonin and its conjugates with antibodies is determined by the extent of their endocytosis.
Goldmacher VS; Scott CF; Lambert JM; McIntyre GD; Blättler WA; Collnhson AR; Stewart JK; Chong LD; Cook S; Slayter HS
J Cell Physiol; 1989 Oct; 141(1):222-34. PubMed ID: 2528553
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of cellular trafficking and cytotoxicity of 9.2.27-gelonin immunotoxins targeted against the high-molecular-weight melanoma-associated antigen.
Chan MC; Murphy RM
Cancer Immunol Immunother; 1999 Feb; 47(6):321-9. PubMed ID: 10203062
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and toxicology of immunotoxins administered into the subarachnoid space in nonhuman primates and rodents.
Muraszko K; Sung C; Walbridge S; Greenfield L; Dedrick RL; Oldfield EH; Youle RJ
Cancer Res; 1993 Aug; 53(16):3752-7. PubMed ID: 8339287
[TBL] [Abstract][Full Text] [Related]
12. [Localization of the site of human transferrin interacting with cellular receptors using monoclonal antibodies].
Rubikaĭte BI; Beresten' SF; Viklitskiĭ V; Slavichkova A
Mol Biol (Mosk); 1991; 25(1):185-93. PubMed ID: 1716735
[TBL] [Abstract][Full Text] [Related]
13. Transferrin toxin but not transferrin receptor immunotoxin is influenced by free transferrin and iron saturation.
Gosselaar PH; van-Dijk AJ; de-Gast GC; Polito L; Bolognesi A; Vooijs WC; Verheul AF; Krouwer HG; Marx JJ
Eur J Clin Invest; 2002 Mar; 32 Suppl 1():61-9. PubMed ID: 11886434
[TBL] [Abstract][Full Text] [Related]
14. Cell surface receptor directed targeting of toxin to human malaria parasite, Plasmodium falciparum.
Surolia N; Misquith S
FEBS Lett; 1996 Oct; 396(1):57-61. PubMed ID: 8906866
[TBL] [Abstract][Full Text] [Related]
15. Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation.
Jiang YY; Liu C; Hong MH; Zhu SJ; Pei YY
Bioconjug Chem; 2007; 18(1):41-9. PubMed ID: 17226956
[TBL] [Abstract][Full Text] [Related]
16. Slowed receptor trafficking in mutant CHO lines of the End1 and End2 complementation groups.
Johnson LS; Presley JF; Park JC; McGraw TE
J Cell Physiol; 1994 Jan; 158(1):29-38. PubMed ID: 8263026
[TBL] [Abstract][Full Text] [Related]
17. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC
Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821
[TBL] [Abstract][Full Text] [Related]
18. Use of immunotoxin to inhibit proliferating human corneal endothelium.
Fulcher S; Lui GM; Houston LL; Ramakrishnan S; Burris T; Polansky J; Alvarado J
Invest Ophthalmol Vis Sci; 1988 May; 29(5):755-9. PubMed ID: 3259213
[TBL] [Abstract][Full Text] [Related]
19. Expression of dominant negative rab5 in HeLa cells regulates endocytic trafficking distal from the plasma membrane.
Dinneen JL; Ceresa BP
Exp Cell Res; 2004 Apr; 294(2):509-22. PubMed ID: 15023538
[TBL] [Abstract][Full Text] [Related]
20. Immunotoxin resistance in multidrug resistant cells.
McGrath MS; Rosenblum MG; Philips MR; Scheinberg DA
Cancer Res; 2003 Jan; 63(1):72-9. PubMed ID: 12517780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]